We offer services in the following areas:
Corporate & Securities
Our corporate and securities attorneys provide assistance to our biotechnology clients with all types of financings, including venture capital and other private financings and public offerings. The securities attorneys are particularly experienced in financings for early-stage biotechnology companies and venture capital investments. Our corporate and securities attorneys have extensive experience in mergers and acquisitions of all sizes, representing buyers, sellers and targets. In coordination with our intellectual property attorneys, they also assist clients with product distribution and technology licensing.
Intellectual Property and Patents
In light of the substantial investments that biotechnology companies make in research and development, the creation and implementation of a program for the protection, exploitation and enforcement of intellectual property is a key element of any biotechnology company's business plan. We assist clients with the full range of intellectual property protection. Patent protection is of particular importance for the biotechnology industry. Our patent attorneys have advanced degrees in chemistry, biology, and botany, as well as the electrical and mechanical arts. They assist clients with the preparation and prosecution of patent applications, domestically and internationally, as well as with licensing (including university licensing), enforcing patent rights and defending against infringement claims.
FDA and Regulatory Experience
Greenberg Traurig assists biotechnology companies in developing and implementing pro-active strategies to affect government actions. Whether it be FDA approval of a new drug or device, instituting a federal procurement requirement, passing a trade agreement or challenging a non-tariff trade barrier, Greenberg Traurig recognizes that Administration and Congressional action can impact the "bottom line" of companies and countries.
Greenberg Traurig represents pharmaceutical, biotechnology and medical device companies and home health care, physicians and long-term care organizations and facilities. The Health Group of Greenberg Traurig provides a wide range of legal services to this diverse group of health care businesses and organizations, including for-profit and not-for-profit hospitals; long-term care providers; health maintenance organizations; provider-affiliated and independent provider networks; physicians and physician groups; integrated delivery systems; hospices; and home health agencies.
Environmental and Land Use
Our environmental and land use attorneys have substantial experience in environmental compliance, enforcement, remediation and litigation issues affecting biotechnology companies, and medical and academic facilities. We represent major public and private universities, and biotechnology companies in both the product development and product manufacturing phases, and companies developing or expanding their manufacturing operations.
Companies in high-technology industries, including the biotechnology industry, often find it necessary to hire scientists, researchers, and other technical experts who are neither U.S. citizens nor permanent residents. Our immigration practice group specializes in assisting our corporate clients to obtain the necessary work visas, employment authorizations, and labor certifications for these employees.
International Trade, Customs and Competition
Greenberg Traurig's international trade and customs lawyers have represented clients in numerous trade regulatory proceedings conducted by the International Trade Commission (ITC), the International Trade Administration of the Department of Commerce (ITA) and the office of the United States Trade Representative (USTR).
The biotechnology industry is a worldwide industry. Our worldwide network and experience in assisting clients with their international operations often prove to be valuable resources, and many of our attorneys are fluent in at least one foreign language. Many of our lawyers have extensive experience representing domestic and foreign biotechnology companies doing business in their respective jurisdictions.